All the news Showing 10 of 772 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Screening and testing policy 90% of people who inject drugs in United States missed opportunities for HIV or hepatitis C tests Keith Alcorn / 27 February 2020 Around 90% of people who inject drugs in the United States missed opportunities for HIV or hepatitis C virus testing between 2010 and 2017, a review of more than 840,000 healthcare visits shows. ... Treatment for people who use drugs Hepatitis C treatment and prevention failing to reach people most affected Keith Alcorn / 25 February 2020 Major gaps in harm reduction and treatment provision for people who inject drugs jeopardise the achievement of global targets for hepatitis C elimination by 2030, a review of hepatitis C treatment and ... Injecting drug use Half of people who inject drugs in Middle East have hepatitis C Keith Alcorn / 24 February 2020 Half of people who inject drugs in the Middle East and north Africa have been infected with hepatitis C, and researchers from Weill Cornell Medicine Qatar estimate that around 221,000 people who ... Harm reduction interventions and policy Increase in clean needle and syringe provision essential for hepatitis C elimination Keith Alcorn / 12 February 2020 Elimination of hepatitis C will not be achievable without substantial improvements in provision of sterile injecting equipment, Dr Magdalena Harris of London School of Hygiene and Tropical Medicine told a conference on hepatitis ... HBV treatment for people with HIV Hepatitis B treatment suboptimal in people with HIV in Africa Keith Alcorn / 04 February 2020 Testing for chronic hepatitis B infection was very low in people living with HIV in Cameroon, a country with a high burden of hepatitis B, and suppression of hepatitis B virus was ... Screening and testing policy London: hepatitis C elimination depends on testing scale-up Keith Alcorn / 28 January 2020 London needs to step up the rate of testing for hepatitis C if it is to achieve elimination of hepatitis C, Professor Graham Foster of Queen Mary University London told the London ... Harm reduction interventions and policy Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs Keith Alcorn / 24 January 2020 Intensive peer support during engagement with hepatitis C care was associated with a high level of engagement in care among vulnerable people including recently homeless people and people who inject drugs in London, ... Models of care HepCheck screening programme links 80% to hepatitis C care in 4 European countries Keith Alcorn / 21 January 2020 Hepatitis C screening programmes targeting the homeless, people who inject drugs and prisoners achieved linkage to specialist care in over 80% of people diagnosed with hepatitis C, a four-country European study found. The study ... Sex between men Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in UK Keith Alcorn / 13 January 2020 Increasing the frequency of hepatitis C screening in gay and bisexual men taking pre-exposure prophylaxis (PrEP) in the United Kingdom has the potential to reduce new hepatitis C infections in ... Hepatocellular carcinoma (HCC) A healthy lifestyle could prevent most liver cancer and liver-related deaths Liz Highleyman / 17 December 2019 A healthy lifestyle, including smoking cessation, moderate drinking, a balanced diet, exercise and weight loss could dramatically reduce the growing burden of liver cancer and deaths due to liver disease, according to a study ... ← First12345...78Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds